AI-generated summary
The authors randomly assigned 30 patients with de Quervain's tenosynovitis to low level laser therapy or ultrasonic therapy, given over seven sessions on alternate days. Both groups improved on tenderness, grip strength and pain scores, but the authors found no statistically significant difference between the two treatments. The study was small and prospective, and the abstract does not state how the laser was dosed.
- Participants
- 30
- Who or what was studied
- Patients clinically diagnosed with de Quervain's tenosynovitis, average age 36 years (range 21 to 45 years)
- Limits stated in the abstract
- The abstract describes a small single prospective study of 30 patients with no reported laser parameters, and it does not state a placebo or sham control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Visual analogue scale, Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.